Skip to main content
Log in

Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The plasma concentration and urinary excretion of methotrexate were followed in twelve psoriatic patients after intravenous and oral doses of methotrexate ranging from 7.5 to 30 mg. In six of the patients, a nonlinear relation was found between the fractional amount of methotrexate excreted in the urine and the corresponding area under the plasma concentration-time curve. The methotrexate clearance was found to be increased during the initial high plasma concentration, probably due to saturation of the tubular reabsorption of methotrexate. Considerable interindividual variation was found in the apparent saturation point of the active reabsorption, but up to 500–800 ng/ml first order kinetics still applied. At plasma concentrations below saturation, the renal clearance of methotrexate ranged from 52–102 ml/min (mean±SD, 83±19.4 ml/min).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Goldie JH, Price LA, Harrap KR (1972) Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern. Eur J Cancer 8: 409–414

    Google Scholar 

  • Goresky CA, Watanabe H, Johns DC (1963) The renal excretion of folic acid. J Clin Invest 42: 1841–1849

    Google Scholar 

  • Hendel J, Sarek LJ, Hvidberg EF (1976) Rapid radioimmunoassay for methotrexate in biological fluids. Clin Chem 22: 813–816

    Google Scholar 

  • Huffman DH, Wan SK, Azarnoff DL, Hoogstraten B (1973) Pharmacokinetics of methotrexate. Clin Pharmacol Ther 14: 572–579

    Google Scholar 

  • Lawrence JR, Steele WH, Stuart JFB, McNeill CA, McVie, Whiting B (1980) Dose dependent methotrexate elimination following bolus intravenous injection. Eur J Clin Pharmacol 17: 371–374

    Google Scholar 

  • Leme PR, Creaven PJ, Allen LM, Bergman M (1975) Kinetic model for the disposition and metabolism of moderate and high dose methotrexate (NSC-740) in man. Cancer Chemother Rep 59: 811–817

    Google Scholar 

  • Liegler DG, Henderson ES, Hahn MA, Oliverio VT (1969) The effect of organic acids on renal clearance of methotrexate in man. Clin Pharmacol Ther 10: 849–857

    Google Scholar 

  • Nyfors A (1980) Methotrexate therapy of psoriasis. Dan Med Bull 27: 74–96

    Google Scholar 

  • Reich DS, Bachur NR, Goebel RH, Bergman M (1977) A pharmacokinetic model for high-dose methotrexate infusions in man. J Pharmacokinet Biopharm 5: 421–433

    Google Scholar 

  • Salasoo S, Irving MG, Freedman A (1976) Methotrexate megadose followed by folate rescue II. Clearance patterns in patients receiving sequential megadose infusions. Med J Austral i: 826–828

    Google Scholar 

  • Shen DD, Azarnoff DL (1978) Clinical Pharmacokinetics of methotrexate. Clin Pharmacokinet 3: 1–13

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hendel, J., Nyfors, A. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption. Eur J Clin Pharmacol 26, 121–124 (1984). https://doi.org/10.1007/BF00546719

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00546719

Key words

Navigation